Zdrowie i gospodarka · 25/10/2017

FDA Extends Comment Period for Animal Generic Drug User Fee Act Reauthorization Draft Recommendations

The Food and Drug Administration (FDA) is seeking public input on draft recommendations for the Animal Generic Drug User Fee Act (AGDUFA) reauthorization, with a 30-day extension of the comment period to allow for more feedback.